Tuberculosis patients are chronically optimistic, but the 100-odd patients at the Lake County tuberculosis sanatorium near Waukegan, 111. really had something to be optimistic about last week. Diasone, the new antituberculosis drug (TIME, Nov. 8), seems to be helping some of them get well.
Energetic, sandy-haired Dr. Charles Kenneth Fetter, who runs the hospital, told the county medical society the results of 120 days of Diasone: 1) of nine minimal cases, every one was improved, most of them showed “marked improvement”; 2) of 42 moderately advanced cases, almost half were much better; 3) about one-fifth of the advanced cases were greatly improved.
As tuberculosis is a slow-moving disease, Dr. Fetter says final results can be known only after months and years. He is cautious: Diasone is “no cure-all,” should not be used outside of sanatoriums, is “not the final answer” to tuberculosis. He is also enthusiastic: Diasone may prove to be “a step ahead, probably ranking with the advent of the sanatorium [rest treatment] and collapse therapy [compressing a sick lung to make it rest].”
More Must-Reads from TIME
- Welcome to the Golden Age of Scams
- Introducing TIME's 2024 Latino Leaders
- How to Make an Argument That’s Actually Persuasive
- Did the Pandemic Break Our Brains?
- 33 True Crime Documentaries That Shaped the Genre
- The Ordained Rabbi Who Bought a Porn Company
- Why Gut Health Issues Are More Common in Women
- The 100 Most Influential People in AI 2024
Contact us at letters@time.com